PT Bundamedik Tbk (IDX:BMHS)
Indonesia · Delayed Price · Currency is IDR 188.00
-2.00 (-1.05%)
Feb 6, 2026, 4:00 PM WIB
PT Bundamedik Tbk Revenue
PT Bundamedik Tbk had revenue of 397.09B IDR in the quarter ending September 30, 2025, with 6.61% growth. This brings the company's revenue in the last twelve months to 1.55T, up 0.41% year-over-year. In the year 2024, PT Bundamedik Tbk had annual revenue of 1.55T with 4.47% growth.
Revenue (ttm)
1.55T
Revenue Growth
+0.41%
P/S Ratio
1.05
Revenue / Employee
998.47M
Employees
1,555
Market Cap
1.63T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.55T | 66.49B | 4.47% |
| Dec 31, 2023 | 1.49T | -170.49B | -10.28% |
| Dec 31, 2022 | 1.66T | -232.11B | -12.28% |
| Dec 31, 2021 | 1.89T | 742.66B | 64.68% |
| Dec 31, 2020 | 1.15T | 183.25B | 18.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.56T |
| PT Medikaloka Hermina Tbk | 6.98T |
| PT Mitra Keluarga Karyasehat Tbk | 5.24T |
| PT Famon Awal Bros Sedaya Tbk | 2.30T |
| PT Sarana Meditama Metropolitan Tbk | 1.79T |
| PT Murni Sadar Tbk | 1.26T |
| PT Kedoya Adyaraya Tbk | 448.65B |
| PT Royal Prima Tbk | 332.14B |